Assessment of the autonomic nervous system in heart failure and in heart transplantation;Il sistema neurovegetativo nello scompenso cardiaco e nel trapianto cardiaco

Italian Heart Journal Supplement

Volumn 2, Issue 8, 2001, Pages 871-887

  Mortara, A ^a  

^a Policlinico di Monza   (Italy)

Author keywords

Autonomic nervous system; Cardiac transplantation; Heart failure; Heart rate; Prognosis; Reflexes; Reinnervation

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN; RENIN;

AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CLINICAL TRIAL; HEART FAILURE; HEART RATE; HEART TRANSPLANTATION; HUMAN; NEUROGRAPHY; PRESSORECEPTOR REFLEX; PROGNOSIS; REVIEW; SYMPATHETIC TONE; VAGUS NERVE;

AUTONOMIC NERVOUS SYSTEM; CATECHOLAMINES; HEART FAILURE, CONGESTIVE; HEART RATE; HEART TRANSPLANTATION; HUMANS; PRESSORECEPTORS;

EID: 0034761186     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
2. The role of neurohormonal activation in the pathophysiology and prognosis of patients with congestive heart failure
3. Heart failure: Role of cardiovascular reflexes
4. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium
5. Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase
6. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
7. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration
8. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: A report from the registry of Studies of Left Ventricular Dysfunction
9. Plasma norepinephrine? Plasma renin activity, and congestive heart failure: Relations to survival and the effects of therapy in V-HeFT II
10. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril
11. Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan
12. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure
13. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure
14. Diastolic ventricular interaction in chronic heart failure: Relation to heart rate variability and neurohumoral status
15. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure
16. Receptor system involved in norepinephrine release in heart failure: Focus on dopaminergic system
17. Comparison of norepinephrine and isoproterenol clearance in congestive heart failure
18. Effect of digitalis on norepinephrine kinetics in congestive heart failure
19. Carotid sinus baroreceptor sensitivity in experimental heart failure
20. Modulation of cardiac autonomic control in humans by angiotensin II
21. ACE inhibition improves vagal reactivity in patients with heart failure
22. Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation
23. Arterial baroreflex abnormalities in heart failure: Reversal after orthotopic cardiac transplantation
24. Defective cardiac parasympathetic control in patients with heart disease
25. Arterial baroreflex modulation of heart rate in chronic heart failure: Clinical and hemodynamic correlates and prognostic implications
26. Assessment of baroreflex sensitivity
27. The variable pressure neck chamber method for studying the carotid baroreflex in man
28. Autonomic pathophysiology in heart failure: Carotid baroreceptor-cardiac reflexes
29. Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure
30. Physiology and pathophysiology of heart rate and blood pressure variability in humans: Is power spectral analysis largely an index of baroreflex gain?
31. Demonstrable cardiac reinnervation after human heart transplantation by carotid baroreflex modulation of RR interval
32. Frequency dependent response of arterial baroreceptors in heart failure: Predominance of modulation of heart rate and blood pressure in the very low frequency bands
33. Assessing baroreflex sensitivity in post-myocardial infarction patients: Comparison of spectral techniques and phenylephrine
34. Human splanchnic and forearm vasoconstrictor responses to reductions of right atrial and aortic pressures
35. Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure
36. Sympathoinhibitory responses to digitalis glicosides in heart failure patients. Direct evidence from sympathetic neural recordings
37. Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure
38. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: Effects of physical training
39. Peripheral chemoreceptors and cardiovascular regulation
40. The reproducibility and comparability of tests of the peripheral chemoreflex: Comparing the transient hypoxic ventilatory drive test and the single-breath carbon dioxide response test in healthy subjects
41. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure
42. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications
43. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure
44. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure
45. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
46. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure
47. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation
48. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure
49. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability
50. Role of the input/output relation of sinoatrial myocytes in cholinergic modulation of heart rate variability
51. Prognostic value of heart rate variability in patients awaiting cardiac transplantation
52. Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure
53. Patterns of beat-to-beat heart rate variability in advanced heart failure
54. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features
55. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure
56. Prognostic implications of autonomic nervous system analysis in chronic heart failure: Role of heart rate variability and baroreflex sensitivity
57. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
58. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy
59. Heart rate variability in idiopathic dilated cardiomyopathy: Relation to disease severity and prognosis
60. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart)
61. Heart rate variability index in congestive heart failure: Relation to clinical variables and prognosis
62. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy
63. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure
64. Reduced low frequency at power spectral analysis of heart rate variability is a powerful predictor of arrhythmic mortality in chronic heart failure
65. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure
66. Five-minute recording of heart rate variability in severe chronic heart failure: Correlates with right ventricular function and prognostic implications
67. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure
68. Assessment of heart rate variability by using different commercially available systems
69. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
70. Intraneural recording and autonomic function in man
71. Importance of aortic baroreflex in regulation of sympathetic responses during hypotension: Evidence from direct sympathetic nerve recordings in man
72. Clinical and hemodynamic correlates of sympathetic neural activity in normal humans and patients with heart failure. Evidence from direct microneurographic recordings
73. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure
74. Is sympathetic neural hyperactivity in chronic heart failure affected by heart transplantation?
75. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure
76. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure
77. Sympathetic neural burst amplitude distribution: A more specific indicator of sympathoexcitation in human heart failure
78. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans
79. Homovital transplantation of the heart
80. Alternative technique for orthotopic heart transplantation
81. Neural responses following autotransplantation of the canine heart
82. Responses to electrical and reflex autonomic stimulation in dogs with cardiac transplantation before and after reinnervation
83. Chronology and mode of reinnervation of the surgically denervated canine heart: Functional and chemical correlates
84. Circulatory responses to electrical and reflex activation of the nervous system after cardiac denervation
85. The heart reinnervates after transplantation
86. Chest pain in cardiac transplant recipients
87. Coronary artery spasm in the denervated transplanted human heart
88. Mechanisms of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation in humans
89. Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans
90. Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans
91. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans
92. Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation
93. Reinnervation of the transplanted human heart as evidenced from heart rate variability studies
94. Heart rate variability after cardiac transplantation in humans
95. Spectral analysis of heart rate variability following human heart transplantation: Evidence for functional reinnervation
96. Autonomic reinnervation after heart transplantation in man
97. Respiratory sinus arrhythmia in the denervated human heart
98. Sympathetic reinnervation of the sinus node and exercise hemodynamics after cardiac transplantation
99. Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation
100. Arterial baroreflex modulation of heart rate in patients early after heart transplantation: Lack of parasympathetic reinnervation
101. Vagal reinnervation in the long term after orthotopic heart transplantation
102. Vasovagal reaction may occur after orthotopic heart transplantation
103. Vasovagal reactions after heart transplantation
104. Vasovagal syncope after infusion of a vasodilator in a heart transplant recipient
105. Sympathetic outflow to muscles during vasovagal syncope
106. Influence of type of surgery on the occurrence of parasympathetic reinnervation after cardiac transplantation
107. The analysis of baroreceptor reflexes allows identification of different patterns of reinnervation after heart transplantation